Abstract
Next to the classical developmental route, in which first CD25 and subsequently Foxp3 are induced to generate thymic regulatory T (Treg) cells, an alternative route has been described. This alternative route is characterized by reciprocal induction of Foxp3 and CD25, with CD25 induction being required to rescue developing Treg cells from Foxp3-induced apoptosis. NF-κB has been demonstrated to be crucial for the development of thymic Treg cells via the classical route. However, its impact on the alternative route is poorly characterized. Using single and double deficient mice for key regulators of the classical route, c-Rel and IκBNS, we here demonstrate that NF-κB is essential for the generation of alternative CD25−Foxp3+ precursors, as well. Thus, c-Rel and IκBNS govern both routes of thymic Treg cell development.
Introduction
Regulatory T (Treg) cells constitute a subset of CD4+ T cells, which is characterized by the expression of the winged-helix transcription factor forkhead box P3 (Foxp3) (1). Treg cells are an essential part of peripheral tolerance (2) and the regulation of Treg cell generation is essential to maintain immune homeostasis (3).
Treg cell development depends on TCR and common gamma chain (γc) cytokine-mediated signals (4, 5). A prominent two-step model suggests that a CD25+Foxp3− cell population contains Treg cell precursors, which develop upon TCR stimulation of CD4 single-positive (SP) thymocytes (6). This stimulation causes the induction of CD25, which makes these CD25+Foxp3− Treg cell precursors receptive for γc-mediated stimuli via e.g., IL-2 or IL-15, which in a second step lead to the differentiation of CD25+Foxp3− precursors into CD25+Foxp3+ mature Treg cells (6, 7). Next to this classical route, an alternative developmental route has been suggested, in which mature CD25+Foxp3+ Treg cells arise from CD25−Foxp3+ cells (8, 9). These alternative precursor cells require stimulation via γc cytokines to upregulate CD25 and to prevent Foxp3-induced apoptosis, hence, allowing differentiation into mature Treg cells in a reversed fashion regarding the order of CD25 and Foxp3 induction (8–11).
On the molecular level, current models suggest that NF-κB is a pioneer transcription factor (12) controlling Foxp3 induction during Treg cell development. Especially two NF-κB components, c-Rel and IκBNS (encoded by the Nfkbid gene), are crucial for directly activating Foxp3 expression (13–17). Specifically, c-Rel and IκBNS bind to the core promoter and the conserved non-coding sequence (CNS) 3 of the Foxp3 locus (16, 17), suggesting that c-Rel and IκBNS act in a common complex and cooperatively regulate Treg cell generation. In addition, NF-κB also promotes another, independent step of Treg cell maturation, namely CD25 induction (18, 19). We could recently show that CD25−Foxp3− cells expressing CD122, which constitutes the IL-2 receptor β-chain, may give rise to CD25+Foxp3− Treg cell precursors of the classical developmental route and can, thus, be considered as Treg cell pre-precursors (19).
Although several studies indicated an important role of NF-κB components, like c-Rel, for the generation of classical CD25+Foxp3− Treg cell precursors, the role of NF-κB for the generation of CD25−Foxp3+ alternative Treg cell precursors is not well-defined. Moreover, it remains unknown how responsiveness of alternative Treg cell precursors to IL-2 is achieved, since they do not express CD25 (the IL-2 receptor α-chain). In this study, we report that the generation of recently described alternative CD25−Foxp3+ Treg cell precursors required IκBNS and c-Rel, since alternative precursor cells were reduced to a similar extent in c-Rel-deficient, IκBNS-deficient and double knock-out (DKO) mice. Corresponding to the recently proposed Treg cell pre-precursors of the classical route, CD25−Foxp3+ alternative Treg cell precursors expressed similar amounts of CD122, and c-Rel contributes to their transition into Foxp3+CD25+ mature Treg cells.
Method
Mice
IκBNS-deficient (Nfkbid−/−) mice (17, 20), c-Rel-deficient (Rel−/−) (21, 22), c-Rel/IκBNS (DKO) double-deficient (19) and Foxp3DTR−eGFP (DEREG) mice (23) used for this study were described before. All animal procedures were performed at the animal facility of the Helmholtz Centre for Infection Research (Braunschweig, Germany) under specific pathogen free conditions and according to current European law with written consent of local authorities.
Flow Cytometry
For flow cytometry, cells were isolated from the respective organs of mice. 1 * 106 cells were washed twice with PBS in small flow cytometric tubes. Cells were incubated for 30 min with fixable Live/Dead 1:1000/PBS at 4°C. Afterwards cells were washed with PBS and incubated for 15 min with antibodies in FACS-buffer (2% BSA/PBS) and afterwards washed with PBS. For CD122 staining cells were additionally incubated with streptavidin-PE. All antibodies [CD4-PacificBlue (Biolegend 100531), CD8-APC (Biolegend 100712), CD8-PerCPeFluor710 (Biolegend 100734), CD25-APC (Biolegend 102012), CD25-FITC (Biolegend 102006), GITR-PECy7, CD122-biotin (Biolegend 123206)] and Streptavidin-PE (eBioscience 12-4317-87) were used in 1:1000 dilution, except anti-humanCD2-FITC (Biolegend 300206) and anti-Foxp3-PE (eBioscience 12-5773-80) antibodies, which were both used in 1:200 dilution.
In vitro Treg Cell Maturation Assay
Thymocytes from mice with the indicated genotype were stained with anti-CD4-PacificBlue (Biolegend 100531) and anti-CD8-APC (Biolegend 100712) to sort CD4+CD8− CD25− eGFP+ (Foxp3) Treg precursors via fluorescence-activated cell sorting (FACS Aria II; BD Biosciences). In DEREG mice, eGFP reports Foxp3 expression and allows for purification of viable Foxp3+ cells. 15,000 cells per well were directly sorted into a 96-well round bottom plate. Subsequently, cells were stimulated with 100 ng/ml IL-15 for 24 h or left untreated. The generation of Treg cell precursors and mature Treg cells was determined via CD25 and Foxp3 staining and flow cytometry.
Statistics
The Graph Pad Prism Software (GraphPad Software) was used for all statistical analyses. To determine statistical significance, the one-tailed or two-tailed Mann–Whitney U-test or ANOVA tests were used and error bars represent the standard error of the mean (SEM).
Results
Alternative CD25−Foxp3+ Treg Cell Precursor Generation Depends on NF-κB
Thymic Treg cells develop from CD4SP thymocytes by inducing CD25 and Foxp3 expression in a two-step manner depending on TCR-induced and γc cytokine-mediated signals (6, 7). Next to this classical route, an alternative route was proposed for the thymic development of Treg cells, in which Foxp3 and CD25 induction is reversed (8). We wondered, whether NF-κB signaling contributed to the generation of alternative CD25−Foxp3+ Treg cell precursors similarly to what has been described for classical CD25+Foxp3− Treg cell precursors (17–19, 24). To this end, we analyzed CD25 and Foxp3 expression in CD4+GITR+ thymocytes from wildtype, IκBNS-deficient, c-Rel-deficient and DKO mice (Figure 1A). Our analyses revealed reduced frequencies (Figure 1B) and absolute numbers (Figure 1C) of alternative Treg cell precursors in IκBNS-deficient, c-Rel-deficient and DKO mice. Since the reduction of CD25−Foxp3+ Treg cell precursors was similar in these mice, c-Rel and IκBNS appear to contribute to the alternative route of Treg cell development in a common pathway. Alternative CD25−Foxp3+ Treg cell precursors express CD122.
Figure 1
Interestingly, γc signaling induces the differentiation of alternative CD25−Foxp3+ Treg cell precursors into Foxp3+CD25+ mature Treg cells (8). Since we described recently that only CD122+ T cells give rise to CD25+Foxp3− Treg cell precursors in the classical route of Treg cell development (19), we here analyzed whether CD25−Foxp3+ alternative Treg cell precursors do express CD122 as well. Indeed, we detected CD25−Foxp3+ cells exclusively in the compartment of CD122+ CD4SP thymocytes, but not within the CD122− fraction (Figure 1D), indicating a comparable role for CD122 in both Treg cell developmental routes. Furthermore, we analyzed CD122 expression during Treg cell development. While CD4+ single positive thymocytes largely lacked CD122 expression, both classical and alternative Treg cell precursors exhibited increased and almost identical expression levels of CD122 (Figures 1E,F). CD122 expression was even further increased in mature Foxp3+CD25+ Treg cells (Figures 1E,F).
Minor Impact of NF-κB for the Development of Alternative CD25−Foxp3+ Treg Cell Precursors Into Mature CD25+Foxp3+ Treg Cells
Since c-Rel, but not IκBNS, regulates the induction of CD25 in the classical route (19), we wondered whether this regulation occurred in the alternative route as well. Thus, we purified alternative Treg cell precursors from wildtype, c-Rel-deficient and IκBNS-deficient Foxp3 reporter mice and treated them with IL-15. Indeed, we detected slightly reduced frequencies of CD25+Foxp3+ Treg cells when c-Rel-deficient alternative Treg cell precursors were stimulated with IL-15 as compared to stimulation of wildtype alternative Treg cell precursors, indicating somewhat impaired CD25 induction (Figures 2A,B). In contrast, IκBNS-deficient Treg cell precursors display a normal differentiation into CD25+Foxp3+ Treg cells. These results indicate that c-Rel regulates Foxp3+CD25− alternative Treg cell precursor generation more pronounced than Treg cell maturation, i.e. CD25 induction. Moreover, IκBNS is dispensable for CD25 expression but crucial for Foxp3 induction in both routes of Treg cell development (Figure 2C).
Figure 2
Discussion
Recent work on NF-κB and Treg cell development has mainly focused on the classical route of Treg cell development. In contrast, it remained unknown whether the generation of CD25−Foxp3+ alternative Treg cell precursors (8) does also depend on NF-κB. Here, we show that c-Rel-deficient, IκBNS-deficient as well as DKO mice display a defect in the generation of alternative Treg cell precursors. So far, the signaling events, which lead to the generation of CD25−Foxp3+ alternative Treg cell precursors are unknown, but our data indicate that it involves a stimulus, which activates NF-κB and involves the components c-Rel and IκBNS. Since TCR stimulation is a prerequisite for Treg cell generation and also a strong stimulus for NF-κB activation, it might be responsible for c-Rel and IκBNS induction.
A second signal required for thymic Treg cell development is through γc cytokine signaling. However, CD25−Foxp3+ alternative Treg cell precursors do not express the high-affinity receptor for IL-2 raising the question how these cells respond to γc cytokines. Our data demonstrates that similar to classical CD25+Foxp3− Treg cell precursors also alternative Treg cell precursors express CD122, i.e., the IL-2 receptor β-chain. Downstream of CD122, c-Rel contributes to CD25 induction in Foxp3 expressing cells, i.e., during maturation of alternative Treg cell precursors to mature Treg cells, albeit to a lesser extent than during generation of CD25+Foxp3− classical Treg cell precursor (19).
Taken together, our previous data showed that during classical Treg cell development c-Rel regulates CD25 induction in contrast to IκBNS (19). Thus, c-Rel is critical for classical CD25+Foxp3− Treg cell precursor generation. In a similar fashion, it contributes to a certain extent to CD25 induction in CD25−Foxp3+ alternative Treg cell precursors. Finally, IκBNS and c-Rel together control the induction of Foxp3 and thereby alternative CD25−Foxp3+ Treg cell precursor generation as well as classical CD25+Foxp3− Treg cell precursor progression (Figure 2C).
Statements
Data availability statement
All datasets generated for this study are included in the manuscript and/or the supplementary files.
Ethics statement
All experiments were performed in accordance with regulations according to FELASA, and animals were handled with care and welfare. The protocol was approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES).
Author contributions
MS and IS designed the study. MS and CP-S performed the experiments and analyzed the data. AV and JH provided essential reagents and contributed to the study design. IS supervised the whole study. All authors wrote and approved the final version of the manuscript.
Funding
This study was funded via the Fritz-Thyssen foundation and the Deutsche Forschungsgemeinschaft (SCHM1586/6-1 and SFB854, project A23N) to IS, and via the Deutsche Forschungsgemeinschaft (SFB854, project B16) to JH.
Acknowledgments
We thank Sabrina Schumann and Christian Kozowsky for their excellent technical assistance and David Dettbarn for mouse husbandry. We are very thankful to Dr. Lothar Groebe for performing cell sorting.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
HoriSNomuraTSakaguchiS. Control of regulatory T cell development by the transcription factor Foxp3. Science. (2003) 299:1057–61. 10.1126/science.1079490
2.
SakaguchiSSakaguchiNAsanoMItohMTodaM. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. (1995) 155:1151–64.
3.
GerondakisSFulfordTSMessinaNLGrumontRJ. NF-kappaB control of T cell development. Nat Immunol. (2014) 15:15–25. 10.1038/ni.2785
4.
HsiehCSLeeHMLioCW. Selection of regulatory T cells in the thymus. Nat Rev Immunol. (2012) 12:157–67. 10.1038/nri3155
5.
JosefowiczSZLuLFRudenskyAY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. (2012) 30:531–64. 10.1146/annurev.immunol.25.022106.141623
6.
LioCWHsiehCS. A two-step process for thymic regulatory T cell development. Immunity. (2008) 28:100–11. 10.1016/j.immuni.2007.11.021
7.
VangKBYangJMahmudSABurchillMAVegoeALFarrarMA. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J Immunol. (2008) 181:3285–90. 10.4049/jimmunol.181.5.3285
8.
TaiXErmanBAlagAMuJKimuraMKatzGet al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity. (2013) 38:1116–28. 10.1016/j.immuni.2013.02.022
9.
MarshallDSinclairCTungSSeddonB. Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells. J Immunol. (2014) 193:5525–33. 10.4049/jimmunol.1402144
10.
TaiXSingerA. Basis of Treg development in the thymus. Cell Cycle. (2014) 13:501–2. 10.4161/cc.27787
11.
OwenDLMahmudSASjaastadLEWilliamsJBSpanierJASimeonovDRet al. Thymic regulatory T cells arise via two distinct developmental programs. Nat Immunol. (2019) 20:195–205. 10.1038/s41590-018-0289-6
12.
HoriS. c-Rel: a pioneer in directing regulatory T-cell lineage commitment?Eur J Immunol. (2010) 40:664–7. 10.1002/eji.201040372
13.
IsomuraIPalmerSGrumontRJBuntingKHoyneGWilkinsonNet al. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med. (2009) 206:3001–14. 10.1084/jem.20091411
14.
LongMParkSGStricklandIHaydenMSGhoshS. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity. (2009) 31:921–31. 10.1016/j.immuni.2009.09.022
15.
RuanQKameswaranVToneYLiLLiouHCGreeneMIet al. Development of Foxp3+ regulatory t cells is driven by the c-Rel enhanceosome. Immunity. (2009) 31:932–40. 10.1016/j.immuni.2009.10.006
16.
ZhengYJosefowiczSChaudhryAPengXPForbushKRudenskyAY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. (2010) 463:808–12. 10.1038/nature08750
17.
SchusterMGlaubenRPlaza-SirventCSchreiberLAnnemannMFloessSet al. IkappaB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor. Immunity. (2012) 37:998–1008. 10.1016/j.immuni.2012.08.023
18.
GrigoriadisGVasanthakumarABanerjeeAGrumontROverallSGleesonPet al. c-Rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells. PLoS ONE. (2011) 6:e26851. 10.1371/journal.pone.0026851
19.
SchusterMPlaza-SirventCMatthiesAMHeiseUJeronABruderDet al. c-REL and IkappaBNS govern common and independent steps of regulatory T cell development from novel CD122-expressing pre-precursors. J Immunol. (2017) 199:920–30. 10.4049/jimmunol.1600877
20.
ToumaMAntoniniVKumarMOsbornSLBobenchikAMKeskinDBet al. Functional role for I kappa BNS in T cell cytokine regulation as revealed by targeted gene disruption. J Immunol. (2007) 179:1681–92. 10.4049/jimmunol.179.3.1681
21.
LiouHCJinZTumangJAndjelicSSmithKALiouML. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol. (1999) 11:361–71. 10.1093/intimm/11.3.361
22.
VisekrunaAHuberMHellhundABothurEReinhardKBolligNet al. c-Rel is crucial for the induction of Foxp3+ regulatory CD4+ T cells but not T(H)17 cells. Eur J Immunol. (2010) 40:671–6. 10.1002/eji.200940260
23.
LahlKLoddenkemperCDrouinCFreyerJArnasonJEberlGet al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med. (2007) 204:57–63. 10.1084/jem.20061852
24.
VangKBYangJPaganAJLiLXWangJGreenJMet al. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J Immunol. (2010) 184:4074–7. 10.4049/jimmunol.0903933
Summary
Keywords
cell differentiation, common γ-chain cytokines, NF-κB, regulatory T cell, thymus, transcription factor
Citation
Schuster M, Plaza-Sirvent C, Visekruna A, Huehn J and Schmitz I (2019) Generation of Foxp3+CD25− Regulatory T-Cell Precursors Requires c-Rel and IκBNS. Front. Immunol. 10:1583. doi: 10.3389/fimmu.2019.01583
Received
15 March 2019
Accepted
25 June 2019
Published
10 July 2019
Volume
10 - 2019
Edited by
Kjetil Taskén, Oslo University Hospital, Norway
Reviewed by
Lawrence Kane, University of Pittsburgh, United States; Christopher E. Rudd, Université de Montréal, Canada; Tobias Bopp, Johannes Gutenberg University Mainz, Germany
Updates
Copyright
© 2019 Schuster, Plaza-Sirvent, Visekruna, Huehn and Schmitz.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ingo Schmitz ingo.schmitz@helmholtz-hzi.de
‡Present Address: Marc Schuster, Miltenyi Biotec, Bergisch Gladbach, Germany
This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.